NASDAQ:URGN

Urogen Pharma Stock Predictions

Healthcare > Biotechnology

Buy URGN

*Your capital is at risk

$26.60

+0.0600 (+0.226%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

URGN Prediction Chart

URGN Predictions History

Latest community submissions for URGN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	Apr 22, 2019	$37.86 +2.21%	$37.04	X	97.79%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for URGN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT UROGEN PHARMA LTD

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by